(Q50848459)

23 March 2018

review article

1 reference

title

Child and adolescent psychopharmacology. Important developmental issues. (English)

1 reference

23 March 2018

1 reference

M C Tosyali

1

1 reference

23 March 2018

L L Greenhill

series ordinal

2

1 reference

23 March 2018

publication date

1 October 1998

1 reference

23 March 2018

Pediatric Clinics of North America

published in

1 reference

23 March 2018

volume

45

1 reference

23 March 2018

issue

5

1 reference

23 March 2018

page(s)

1021-35, vii

1 reference

23 March 2018

Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Gender and comorbid psychopathology in adolescents with alcohol dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Attention-deficit hyperactivity disorder and juvenile mania: an overlooked comorbidity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Discrepancies among mother, child, and teacher reports: examining the contributions of maternal depression and anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Cigarette smoking, major depression, and other psychiatric disorders among adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Valproic acid hepatic fatalities. III. U.S. experience since 1986.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Psychiatry is more than a science

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Maternal depression and child development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Model for the kinetics of imipramine and its metabolites in adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Valproic acid hepatic fatalities: a retrospective review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

The need for a new medical model: a challenge for biomedicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Phenobarbital for febrile seizures--effects on intelligence and on seizure recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15 year olds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Chlorpromazine disposition in relation to age in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Depression in 11-16-year-old girls: the role of past parental psychopathology and exposure to recent life events.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Clonazepam in childhood anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Pharmacotherapy of disorders of adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Role of tobacco smoking in pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

The epidemiology of obsessive-compulsive disorder in five US communities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Initial Anticholinergic Prophylaxis for Neuroleptic-Induced Extrapyramidal Syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Presentation and course of major depressive disorder during childhood and later years of the life span

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

A controlled family history study of childhood-onset depressive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Childhood conduct problems, attention deficit behaviors, and adolescent alcohol, tobacco, and illicit drug use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Phenomenology of adolescent and adult mania in hospitalized patients with bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Interpersonal psychotherapy for depressed adolescents: a one-year naturalistic follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Modification of interpersonal psychotherapy with depressed adolescents (IPT-A): phase I and II studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Newer antidepressants and the cytochrome P450 system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Parent-child agreement in prepubertal depression: findings with a modified assessment method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Abrupt cessation of high-dose imipramine treatment in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Imipramine in prepubertal major depressive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Clinical pharmacokinetics in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Concordance between mothers' reports and children's self-reports of depressive symptoms: a longitudinal study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Imipramine in adolescent major depression: plasma level and clinical response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Human brain dopamine receptors in children and aging adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Cognitive therapy with children and adolescents: from theory to practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

7 January 2021

What physicians know.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Influence of age and smoking on drug kinetics in man: studies using model compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Medication development and testing in children and adolescents. Current problems, future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Offspring of Depressed Parents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Psychotropic drugs and alcohol: Pharmacokinetic and pharmaco dynamic interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Controlled trial of a brief cognitive-behavioural intervention in adolescent patients with depressive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

A pharmacological approach to the quagmire of comorbidity in juvenile mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

Plasma noradrenaline increases with age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970060-2

10.1016/S0031-3955(05)70060-2

7 January 2021

Identifiers

DOI

1 reference

23 March 2018

PubMed ID

9884673

1 reference

23 March 2018